CLNE vs CLOV
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 24, 2026
CLNE
CLOV
Investment Advisor Scores
CLOV
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CLNE | CLOV | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 6.8966 | 37.7358 | CLNE |
| PEG Ratio | 4.7217 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 3.7% | 55.6% | CLOV |
| Earnings Growth | 512.0% | 0.0% | CLNE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 53.5/100 | 36.6/100 | CLNE |
| Profit Margin | -21.3% | -0.7% | CLOV |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | SELL | CLNE |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CLNE
MarkdownPrice below a falling SMA50 (slope -10.5%), weak momentum, RSI 41
CLOV
DistributionPrice near a flattening SMA50 (slope -3.2%) with fading momentum, RSI 48
Fundamentals Snapshot
| Metric | CLNE | CLOV |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -39.0 | 29.2 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.6% |
| Gross Margin | 0.3% | 0.2% |
| Operating Margin | 0.0% | 0.0% |
| EPS | -0.43 | -0.05 |
| Dividend Yield | — | — |